Professor
Johns Hopkins University School of Medicine
Dr. Chisolm is ABAM-certifed in addiction medicine and an established researcher with her own research program focusing on treatment of substance-dependent pregnant patients. She has co-authored over 20 peer-reviewed scientific publications. Initially, her projects focused on the relationship between cigarette smoking and depression in drug-dependent pregnant patients with studies of the association between smoking and mood disorders, assessment of tools to screen for mood disorders, and pharmacologic interventions to address smoking in this population. She was the first investigator to retrospectively compare smoking outcomes in depressed drug-dependent pregnant patients treated with bupropion, citalopram, and escitalopram and has also examined the relationship between neonatal outcomes and cigarette smoking among depressed and non-depressed opioid-dependent pregnant patients treated with buprenorphine and methadone. She is currently Principal Investigator (PI) on a NIDA-funded R01 that utilizes an existing efficacious model of drug abuse treatment, Reinforcement Based Treatment (RBT), to generate valuable new information critical to treatment services delivery for a special population of drug-addicted pregnant women.